QUARTERLY RESULTS
Sun Pharmaceutical Industries Ltd.
BSE
Apr 30
1830.20
+25.40 (+ 1.41%)
Volume
34570
Prev. Close
1804.80
Open Price
1809.70
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
1832.30
+26.80 (+ 1.48%)
Volume
2667314
Prev. Close
1805.50
Open Price
1810.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE044A01036
|
Market Cap. ( ₹ in Cr. )
|
439630.15
|
P/BV
|
6.36
|
Book Value ( ₹ )
|
288.06
|
|
BSE Code
|
524715
|
52 Week High/Low ( ₹ )
|
1960/1377
|
FV/ML
|
1/1
|
P/E(X)
|
45.91
|
|
NSE Code
|
SUNPHARMAEQ
|
Book Closure
|
06/02/2025
|
EPS ( ₹ )
|
39.91
|
Div Yield (%)
|
0.74
|
(₹ in Crs.)
| Net Sales/Income from operations | 5985.33 | 5127.71 | 4498.07 | 5639.14 | 4903.66 |
| Other Operating Income | 206.48 | 0.00 | 0.00 | 0.00 | 170.09 |
| Total Income From Operations | 6191.81 | 5127.71 | 4498.07 | 5639.14 | 5073.75 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1162.73 | 1225.01 | 973.23 | 1055.87 | 1121.64 |
| Purchase of Traded Goods | 367.48 | 360.09 | 306.26 | 289.50 | 227.20 |
| Increase/Decrease in Stocks | 131.29 | -142.86 | -55.53 | -29.97 | 129.13 |
| Employees Cost | 651.68 | 662.19 | 645.48 | 575.97 | 590.13 |
| Depreciation | 290.97 | 285.53 | 369.81 | 393.04 | 399.60 |
| Other Expenses | 2175.16 | 1684.66 | 1867.56 | 1854.24 | 1646.65 |
| Total Expenses | 4779.31 | 4074.62 | 4106.81 | 4138.65 | 4114.35 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1412.50 | 1053.09 | 391.26 | 1500.49 | 959.40 |
| Other Income | 68.39 | 86.30 | 82.74 | 118.88 | 76.80 |
| P/L Before Interest, Excpt. Items & Tax | 1480.89 | 1139.39 | 474.00 | 1619.37 | 1036.20 |
| Interest | 215.96 | 243.75 | 216.08 | 217.59 | 214.92 |
| P/L Before Exceptional Items & Tax | 1264.93 | 895.64 | 257.92 | 1401.78 | 821.28 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -69.81 |
| P/L Before Tax | 1264.93 | 895.64 | 257.92 | 1401.78 | 751.47 |
| Tax | 83.88 | 32.35 | 20.10 | 534.18 | 30.16 |
| P/L After Tax from Ordinary Activities | 1181.05 | 863.29 | 237.82 | 867.60 | 721.31 |
| Net Profit/Loss For the Period | 1181.05 | 863.29 | 237.82 | 867.60 | 721.31 |
| | | | | | |
| Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 4.90 | 3.60 | 1.00 | 3.60 | 3.00 |
| Diluted EPS (Rs.) | 4.90 | 3.60 | 1.00 | 3.60 | 3.00 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 4.90 | 3.60 | 1.00 | 3.60 | 3.00 |
| Diluted EPS (Rs.) | 4.90 | 3.60 | 1.00 | 3.60 | 3.00 |
| | | | | | |
| PBITOE Margin (%) | 22.81 | 20.53 | 8.69 | 26.60 | 18.90 |
| PBTE Margin (%) | 20.42 | 17.46 | 5.73 | 24.85 | 16.18 |
| PBT Margin (%) | 20.42 | 17.46 | 5.73 | 24.85 | 14.81 |
| PAT Margin (%) | 19.07 | 16.83 | 5.28 | 15.38 | 14.21 |